Rendapid
Brand names,
Rendapid
Analogs
Rendapid
Brand Names Mixture
Rendapid
Chemical_Formula
C25H38O5
Rendapid
RX_link
http://www.rxlist.com/cgi/generic/simva.htm
Rendapid
fda sheet
Rendapid
msds (material safety sheet)
Rendapid
Synthesis Reference
W. F. Hoffman et al., U.S. Pat. 4,444,784 (1984)
Rendapid
Molecular Weight
418.566 g/mol
Rendapid
Melting Point
135-138oC
Rendapid
H2O Solubility
0.76 mg/L
Rendapid
State
Solid
Rendapid
LogP
4.937
Rendapid
Dosage Forms
Tablet (oral)
Rendapid
Indication
For the treatment of hypercholesterolemia.
Rendapid
Pharmacology
Simvastatin, the methylated form of lovastatin, is an oral antilipemic agent which inhibits HMG-CoA reductase. simvastatin is used in the treatment of primary hypercholesterolemia and is effective in reducing total and LDL-cholesterol as well as plasma triglycerides and apolipoprotein B.
Rendapid
Absorption
Absorption of simvastatin, estimated relative to an intravenous reference dose, in each of two animal species tested, averaged about 85% of an oral dose. In animal studies, after oral dosing, simvastatin achieved substantially higher concentrations in the liver than in non-target tissues.
Rendapid
side effects and Toxicity
No information avaliable
Rendapid
Patient Information
Patients should be advised about substances they should not take concomitantly with simvastatin and be
advised to report promptly unexplained muscle pain, tenderness, or weakness. Patients should also be advised to
inform other physicians prescribing a new medication that they are taking ZOCOR.
Rendapid
Organisms Affected
Humans and other mammals